RGD Reference Report - Common variation at the 11-β hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass. - Rat Genome Database

RGD Reference Report - Common variation at the 11-β hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass. - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

General

Common variation at the 11-β hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass.
Authors:	Rahman, Thahira J Mayosi, Bongani M Hall, Darroch Avery, Peter J Stewart, Paul M Connell, John M C Watkins, Hugh Keavney, Bernard
Citation:	Rahman TJ, etal., Circ Cardiovasc Genet. 2011 Apr;4(2):156-62. doi: 10.1161/CIRCGENETICS.110.958496. Epub 2011 Mar 14.
RGD ID:	329901915
Pubmed:	PMID:21402901 (View Abstract at PubMed)
DOI:	DOI:10.1161/CIRCGENETICS.110.958496 (Journal Full-text)
BACKGROUND: Polymorphisms in 11-β hydroxysteroid dehydrogenase type 1 (11β-HSD1, encoded by HSD11B1) have been reported to be associated with obesity-related cardiovascular risk factors, such as type II diabetes and hypertension. Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular death associated with these factors but has significant additional heritability, the cause of which is undetermined. The 11β-HSD1 is believed to maintain tonic inhibition of the mineralocorticoid receptor in cardiomyocytes, and mineralocorticoid receptor activation is involved in the pathophysiology of LVH. We assessed the association between polymorphisms in the HSD11B1 gene and left ventricular mass (LVM) in 248 families ascertained through a proband with hypertension. METHODS AND RESULTS: LVM was measured by electrocardiography and echocardiography in 868 and 829 participants, respectively. Single-nucleotide polymorphisms (SNPs) tagging common variation in the HSD11B1 gene were genotyped by mass spectrometry. The rs846910 SNP, which lies in the flanking region 5' to exon 1B of HSD11B1, was associated with LVM both by electrocardiography (≈5% lower LVM per copy of the rare allele, P=0.02) and by echocardiography (≈10% lower LVM per copy of the rare allele, P=0.003). Genotype explained 1% to 2% of the population variability in LVM, or approximately 5% of the heritable fraction. There were no significant associations between any HSD11B1 SNP and blood pressure or body mass index that could have confounded the association with LVM. CONCLUSIONS: Genotype at HSD11B1 has a small, but significant effect on LVM, apparently independently of any effect on obesity-related traits. These findings suggest a novel action of 11β-HSD1 in the human cardiomyocyte, which may be of therapeutic importance.

Annotation Click to see Annotation Detail View

RGD Manual Disease Annotations Click to see Annotation Detail View

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Notes	Source	Original Reference(s)
HSD11B1	Human	Left Ventricular Hypertrophy	susceptibility	IAGP		DNA:SNP:5'utr: (rs846910) (human)	RGD

Phenotype Annotations Click to see Annotation Detail View

Manual Human Phenotype Annotations - RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Notes	Source	Original Reference(s)
HSD11B1	Human	Left ventricular hypertrophy	susceptibility	IAGP		DNA:SNP:5'utr: (rs846910) (human)	RGD

Objects Annotated

Genes (Homo sapiens)

HSD11B1 (hydroxysteroid 11-beta dehydrogenase 1)

Additional Information